Opko Health Stock Performance
| OPK Stock | USD 1.47 0.01 0.68% |
The company holds a Beta of -0.0826, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Opko Health are expected to decrease at a much lower rate. During the bear market, Opko Health is likely to outperform the market. At this point, Opko Health has a negative expected return of -0.0195%. Please make sure to check Opko Health's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Opko Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Opko Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Opko Health is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 153.2 M |
Opko |
Opko Health Relative Risk vs. Return Landscape
If you would invest 151.00 in Opko Health on October 3, 2024 and sell it today you would lose (4.00) from holding Opko Health or give up 2.65% of portfolio value over 90 days. Opko Health is generating negative expected returns assuming volatility of 2.2069% on return distribution over 90 days investment horizon. In other words, 19% of stocks are less volatile than Opko, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Opko Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opko Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Opko Health, and traders can use it to determine the average amount a Opko Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0088
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OPK |
Estimated Market Risk
| 2.21 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Opko Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Opko Health by adding Opko Health to a well-diversified portfolio.
Opko Health Fundamentals Growth
Opko Stock prices reflect investors' perceptions of the future prospects and financial health of Opko Health, and Opko Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Opko Stock performance.
| Return On Equity | -0.0939 | ||||
| Return On Asset | -0.0897 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.62) % | ||||
| Current Valuation | 1.09 B | ||||
| Shares Outstanding | 672.8 M | ||||
| Price To Earning | 7.46 X | ||||
| Price To Book | 0.70 X | ||||
| Price To Sales | 1.39 X | ||||
| Revenue | 863.5 M | ||||
| EBITDA | (65.52 M) | ||||
| Cash And Equivalents | 210.46 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 326.56 M | ||||
| Debt To Equity | 0.16 % | ||||
| Book Value Per Share | 2.06 X | ||||
| Cash Flow From Operations | (28.2 M) | ||||
| Earnings Per Share | (0.19) X | ||||
| Total Asset | 2.01 B | ||||
| Retained Earnings | (2.01 B) | ||||
| Current Asset | 454.06 M | ||||
| Current Liabilities | 251.9 M | ||||
About Opko Health Performance
By examining Opko Health's fundamental ratios, stakeholders can obtain critical insights into Opko Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Opko Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5767 people.Things to note about Opko Health performance evaluation
Checking the ongoing alerts about Opko Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Opko Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Opko Health generated a negative expected return over the last 90 days | |
| Opko Health may become a speculative penny stock | |
| The company reported the last year's revenue of 863.5 M. Reported Net Loss for the year was (188.86 M) with profit before taxes, overhead, and interest of 214.3 M. | |
| Opko Health has about 210.46 M in cash with (28.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
| Opko Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 54.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Opko Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Opko Health's stock is overvalued or undervalued compared to its peers.
- Examining Opko Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Opko Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Opko Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Opko Health's stock. These opinions can provide insight into Opko Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.